Division of Endocrinology, Department of Medicine, Medstar Washington Hospital Center, Washington Hospital Center, Northwest, Washington, District of Columbia, USA
Search for other papers by Joanna Klubo-Gwiezdzinska in
Google Scholar
PubMed
Search for other papers by John Costello Jr in
Google Scholar
PubMed
Search for other papers by Kirk Jensen in
Google Scholar
PubMed
Search for other papers by Aneeta Patel in
Google Scholar
PubMed
Search for other papers by Rok Tkavc in
Google Scholar
PubMed
Search for other papers by Douglas Van Nostrand in
Google Scholar
PubMed
Search for other papers by Kenneth D Burman in
Google Scholar
PubMed
Search for other papers by Leonard Wartofsky in
Google Scholar
PubMed
Search for other papers by Vasyl Vasko in
Google Scholar
PubMed
Introduction Standard treatment of thyroid cancer consists of surgical resection and radioiodine ( 131 I) therapy ( 1 ). Depending on the risk stratification of the individual patient, the primary goal of the application of radioactive iodine
Search for other papers by Peter D Mark in
Google Scholar
PubMed
Search for other papers by Mikkel Andreassen in
Google Scholar
PubMed
Department of Medicine O, Department of Clinical Physiology and Nuclear Medicine, Department of Clinical Physiology, Faculty of Health Sciences, Center for Functional and Diagnostic Imaging and Research, Centre of Endocrinology and Metabolism, Herlev University Hospital, Herlev Ringvej 75, Herlev DK‐2730, Denmark
Search for other papers by Claus L Petersen in
Google Scholar
PubMed
Department of Medicine O, Department of Clinical Physiology and Nuclear Medicine, Department of Clinical Physiology, Faculty of Health Sciences, Center for Functional and Diagnostic Imaging and Research, Centre of Endocrinology and Metabolism, Herlev University Hospital, Herlev Ringvej 75, Herlev DK‐2730, Denmark
Search for other papers by Andreas Kjaer in
Google Scholar
PubMed
Department of Medicine O, Department of Clinical Physiology and Nuclear Medicine, Department of Clinical Physiology, Faculty of Health Sciences, Center for Functional and Diagnostic Imaging and Research, Centre of Endocrinology and Metabolism, Herlev University Hospital, Herlev Ringvej 75, Herlev DK‐2730, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
endogenous SH (4, 5, 6) . We have previously evaluated cardiac performance before and after radioactive iodine treatment of SH by means of the impedance cardiography technique, aiming at normalization of serum TSH levels, and found a reduction in both HR and
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Jan Calissendorff in
Google Scholar
PubMed
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Henrik Falhammar in
Google Scholar
PubMed
radioactive iodine, where thyrocytes are exposed to local radiation, with a subsequent decline of hormone secretion. In these two latter alternatives hypothyroidism is a deliberate goal, treated by life-long levothyroxine. Pharmacologic therapy is often
Search for other papers by Muthiah Subramanian in
Google Scholar
PubMed
Search for other papers by Manu Kurian Baby in
Google Scholar
PubMed
Search for other papers by Krishna G Seshadri in
Google Scholar
PubMed
propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease . Thyroid 1995 5 243 – 247 . ( doi:10.1089/thy.1995.5.243 ). 11 Walter MA Christ-Crain M
Search for other papers by Yanling Cai in
Google Scholar
PubMed
Search for other papers by Yan Yang in
Google Scholar
PubMed
Search for other papers by Xiao Pang in
Google Scholar
PubMed
Search for other papers by Suping Li in
Google Scholar
PubMed
. TC among male patients tends to be more aggressive at the time of diagnosis and may be associated with a poor prognosis ( 1 , 2 ). This implies a higher TC risk stratification in men. Radioactive iodine therapy (RAI or 131 I therapy) is the main
Search for other papers by Sara Ahmadi in
Google Scholar
PubMed
Search for other papers by Alexandra Coleman in
Google Scholar
PubMed
Endocrinology Service, Instituto Nacional de Câncer, Rio de Janeiro, Brazil
Search for other papers by Nathalie Silva de Morais in
Google Scholar
PubMed
Search for other papers by Iñigo Landa in
Google Scholar
PubMed
Search for other papers by Theodora Pappa in
Google Scholar
PubMed
Search for other papers by Alex Kang in
Google Scholar
PubMed
Search for other papers by Matthew I Kim in
Google Scholar
PubMed
Search for other papers by Ellen Marqusee in
Google Scholar
PubMed
Search for other papers by Erik K Alexander in
Google Scholar
PubMed
to treatment in all cases. Planar scintigraphy and SPECT-CT were performed 5–7 days after radioactive iodine treatment. All patients receiving I-131 therapy had undergone near-total thyroidectomy as the primary treatment of the disease. Imaging was
Search for other papers by Shih-Rong Lin in
Google Scholar
PubMed
Search for other papers by Shih-Fen Chen in
Google Scholar
PubMed
Search for other papers by Yu-Cih Yang in
Google Scholar
PubMed
Search for other papers by Chung-Y Hsu in
Google Scholar
PubMed
Department of Psychiatry, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan
School of Medicine, Tzu Chi University, Hualien, Taiwan
Search for other papers by Yu-Chih Shen in
Google Scholar
PubMed
.81–1.97) a Per 1000 person-years; b relative hazard ratio; c adjusted for hyperthyroidism, age, gender, CCI score, comorbidities and antithyroid therapy in Cox regression analyzes (antithyroid therapy, including antithyroid drugs, radioactive iodine
Search for other papers by Qian Yang in
Google Scholar
PubMed
Search for other papers by Wencai Ke in
Google Scholar
PubMed
Search for other papers by Fanfan Pan in
Google Scholar
PubMed
Search for other papers by Xinmei Huang in
Google Scholar
PubMed
Search for other papers by Jun Liu in
Google Scholar
PubMed
Search for other papers by Bingbing Zha in
Google Scholar
PubMed
Introduction Graves' disease (GD), also known as an organ-specific autoimmune disorder, is characterized by high radioactive iodine uptake (RAIU) and hyperthyroidism ( 1 ). Excessive production of thyroid hormones results in a substantially
Search for other papers by Xichang Wang in
Google Scholar
PubMed
Search for other papers by Xiaochun Teng in
Google Scholar
PubMed
Search for other papers by Chenyan Li in
Google Scholar
PubMed
Search for other papers by Yushu Li in
Google Scholar
PubMed
Search for other papers by Jing Li in
Google Scholar
PubMed
Search for other papers by Weiping Teng in
Google Scholar
PubMed
Search for other papers by Zhongyan Shan in
Google Scholar
PubMed
Search for other papers by Yaxin Lai in
Google Scholar
PubMed
, 5 ), and hyperthyroid crisis can even be life-threatening. Treatment options for hyperthyroidism mainly include anti-thyroid drugs (ATDs), radioactive iodine (RAI) and thyroidectomy, as well as β-blockers as ancillary therapy. With the
Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed
Search for other papers by Paulina Tomczuk-Bobik in
Google Scholar
PubMed
Search for other papers by Anna Beata Popławska-Kita in
Google Scholar
PubMed
Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
Search for other papers by Angelika Buczyńska in
Google Scholar
PubMed
Search for other papers by Piotr Szumowski in
Google Scholar
PubMed
Search for other papers by Łukasz Żukowski in
Google Scholar
PubMed
Search for other papers by Janusz Myśliwiec in
Google Scholar
PubMed
Search for other papers by Monika Zbucka-Krętowska in
Google Scholar
PubMed
Search for other papers by Marcin Adamski in
Google Scholar
PubMed
Clinical Research Centre, Medical University of Bialystok, Białystok, Poland
Search for other papers by Adam Jacek Krętowski in
Google Scholar
PubMed
force on thyroid nodules and differentiated thyroid cancer . Thyroid 2016 26 1 – 133 . ( https://doi.org/10.1089/thy.2015.0020 ) 3 Evranos B Faki S Polat SB Bestepe N Ersoy R Cakir B . Effects of radioactive iodine therapy on ovarian